메뉴 건너뛰기




Volumn 34, Issue 2, 2012, Pages 112-121

New windows, same old house: An update on acute stroke management

Author keywords

Alteplase; Clinical pharmacy; Emergency medicine; stroke; Tpa

Indexed keywords

FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84861141124     PISSN: 19314485     EISSN: None     Source Type: Journal    
DOI: 10.1097/TME.0b013e3182542bce     Document Type: Article
Times cited : (7)

References (44)
  • 1
    • 34247844511 scopus 로고    scopus 로고
    • Guidelines for the early management of adults with ischemic stroke: A guideline from the American Heart Association
    • American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy ofNeurology affirms the value of this guideline as an educational tool for neurologists
    • Adams, H. P., Jr., Del Zoppo, G., Alberts, M. J., Bhatt, D. L., Brass, L., Furlan, A., Wijdicks, E. F. (2007). Guidelines for the early management of adults with ischemic stroke: A guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy ofNeurology affirms the value of this guideline as an educational tool for neurologists. Stroke, 38(5), 1655-1711.
    • (2007) Stroke , vol.38 , Issue.5 , pp. 1655-1711
    • Adams Jr., H.P.1    Del Zoppo, G.2    Alberts, M.J.3    Bhatt, D.L.4    Brass, L.5    Furlan, A.6    Wijdicks, E.F.7
  • 2
    • 45949109467 scopus 로고    scopus 로고
    • Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition)
    • DOI 10.1378/chest.08-0720
    • Albers, G. W., Amarenco, P., Easton, J. D., Sacco, R. L., & Teal, P. (2008). Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th ed.). Chest, 133(6, Suppl.), 630S-669S. (Pubitemid 351892974)
    • (2008) Chest , vol.133 , Issue.6 SUPPL. 6
    • Albers, G.W.1    Amarenco, P.2    Easton, J.D.3    Sacco, R.L.4    Teal, P.5
  • 4
    • 0041917474 scopus 로고    scopus 로고
    • Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome
    • DOI 10.1161/01.STR.0000085087.41330.FF
    • Baird, T. A., Parsons, M. W., Phanh, T., Butcher, K. S., Desmond, P. M., Tress, B. M., Davis, S.M. (2003). Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke, 34(9), 2208-2214. (Pubitemid 37099838)
    • (2003) Stroke , vol.34 , Issue.9 , pp. 2208-2214
    • Baird, T.A.1    Parsons, M.W.2    Phanh, T.3    Butcher, K.S.4    Desmond, P.M.5    Tress, B.M.6    Colman, P.G.7    Chambers, B.R.8    Davis, S.M.9
  • 5
    • 0033021740 scopus 로고    scopus 로고
    • Mapping the ischaemic penumbra with PET: Implications for acute stroke treatment
    • Baron, J. C. (1999). Mapping the ischaemic penumbra with PET: Implications for acute stroke treatment. Cerebrovascular Diseases, 9(4), 193-201.
    • (1999) Cerebrovascular Diseases , vol.9 , Issue.4 , pp. 193-201
    • Baron, J.C.1
  • 7
    • 0344588816 scopus 로고    scopus 로고
    • Timing for fever-related brain damage in acute ischemic stroke
    • Castillo, J., Davalos, A., Marrugat, J., & Noya, M. (1998). Timing for fever-related brain damage in acute ischemic stroke. Stroke, 29(12), 2455-2460. (Pubitemid 28543989)
    • (1998) Stroke , vol.29 , Issue.12 , pp. 2455-2460
    • Castillo, J.1    Davalos, A.2    Marrugat, J.3    Noya, M.4
  • 9
    • 0033485522 scopus 로고    scopus 로고
    • Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: A randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke
    • Clark, W. M., Wissman, S., Albers, G. W., Jhamandas, J. H., Madden, K. P., & Hamilton, S. (1999). Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: A randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA, 282(21), 2019-2026.
    • (1999) JAMA , vol.282 , Issue.21 , pp. 2019-2026
    • Clark, W.M.1    Wissman, S.2    Albers, G.W.3    Jhamandas, J.H.4    Madden, K.P.5    Hamilton, S.6
  • 10
    • 0032860798 scopus 로고    scopus 로고
    • Pathophysiological topography of acute ischemia by combined diffusion- weighted and perfusion MRI
    • Darby, D. G., Barber, P. A., Gerraty, R. P., Desmond, P. M., Yang, Q., Parsons, M., Davis, S. M. (1999). Pathophysiological topography of acute ischemia by combined diffusion-weighted and perfusion MRI. Stroke, 30(10), 2043-2052. (Pubitemid 29473247)
    • (1999) Stroke , vol.30 , Issue.10 , pp. 2043-2052
    • Darby, D.G.1    Barber, P.A.2    Gerraty, R.P.3    Desmond, P.M.4    Yang, Q.5    Parsons, M.6    Li, T.7    Tress, B.M.8    Davis, S.9
  • 11
    • 68749100878 scopus 로고    scopus 로고
    • Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: A science advisory from the American Heart Association/American Stroke Association
    • Del Zoppo, G. J., Saver, J. L., Jauch, E. C., & Adams, H. P., Jr. (2009). Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: A science advisory from the American Heart Association/American Stroke Association. Stroke, 40(8), 2945-2948.
    • (2009) Stroke , vol.40 , Issue.8 , pp. 2945-2948
    • Del Zoppo, G.J.1    Saver, J.L.2    Jauch, E.C.3    Adams Jr., H.P.4
  • 12
    • 0032930284 scopus 로고    scopus 로고
    • Serum glucose level and diabetes predict tissue plasminogen activator- related intracerebral hemorrhage in acute ischemic stroke
    • Demchuk, A. M., Morgenstern, L. B., Krieger, D.W., Linda Chi, T., Hu, W.,Wein, T. H., Buchan, A. M. (1999). Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke. Stroke, 30(1), 34-39. (Pubitemid 29029438)
    • (1999) Stroke , vol.30 , Issue.1 , pp. 34-39
    • Demchuk, A.M.1    Morgenstern, L.B.2    Krieger, D.W.3    Chi, T.L.4    Hu, W.5    Wein, T.H.6    Hardy, R.J.7    Grotta, J.C.8    Buchan, A.M.9
  • 13
    • 26644435986 scopus 로고    scopus 로고
    • Life-threatening orolingual angioedema during thrombolysis in acute ischemic stroke
    • DOI 10.1007/s00415-005-0789-9
    • Engelter, S. T., Fluri, F., Buitrago-Tellez, C., Marsch, S., Steck, A. J., Ruegg, S., Lyrer, P. A. (2005). Lifethreatening orolingual angioedema during thrombolysis in acute ischemic stroke. Journal of Neurology, 252(10), 1167-1170. (Pubitemid 41443614)
    • (2005) Journal of Neurology , vol.252 , Issue.10 , pp. 1167-1170
    • Engelter, S.T.1    Fluri, F.2    Buitrago-Tellez, C.3    Marsch, S.4    Steck, A.J.5    Ruegg, S.6    Lyrer, P.A.7
  • 14
    • 0030932288 scopus 로고    scopus 로고
    • Characterizing the target of acute stroke therapy
    • Fisher, M. (1997). Characterizing the target of acute stroke therapy. Stroke, 28(4), 866-872. (Pubitemid 27161476)
    • (1997) Stroke , vol.28 , Issue.4 , pp. 866-872
    • Fisher, M.1
  • 15
    • 33646705400 scopus 로고    scopus 로고
    • Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): Evidence of safety and efficacy 3 to 9 hours after stroke onset
    • DOI 10.1161/01.STR.0000217403.66996.6d, PII 0000767020060500000028
    • Furlan, A. J., Eyding, D., Albers, G. W., Al-Rawi, Y., Lees, K. R., Rowley, H. A., Hacke, W. (2006). Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): Evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke, 37(5), 1227-1231. (Pubitemid 43731867)
    • (2006) Stroke , vol.37 , Issue.5 , pp. 1227-1231
    • Furlan, A.J.1    Eyding, D.2    Albers, G.W.3    Al-Rawi, Y.4    Lees, K.R.5    Rowley, H.A.6    Sachara, C.7    Soehngen, M.8    Warach, S.9    Hacke, W.10
  • 16
    • 0842332597 scopus 로고    scopus 로고
    • Blood pressure management in patients with acute ischemic stroke
    • DOI 10.1161/01.HYP.0000113297.76013.51
    • Goldstein, L. B. (2004). Blood pressure management in patients with acute ischemic stroke. Hypertension, 43(2), 137-141. (Pubitemid 38174162)
    • (2004) Hypertension , vol.43 , Issue.2 , pp. 137-141
    • Goldstein, L.B.1
  • 17
    • 56249110590 scopus 로고    scopus 로고
    • Emergency department evaluation and management of stroke: Acute assessment, stroke teams and care pathways
    • viii
    • Gorelick, A. R., Gorelick, P. B., & Sloan, E. P. (2008). Emergency department evaluation and management of stroke: Acute assessment, stroke teams and care pathways. Neurology Clinics, 26(4), 923-942, viii.
    • (2008) Neurology Clinics , vol.26 , Issue.4 , pp. 923-942
    • Gorelick, A.R.1    Gorelick, P.B.2    Sloan, E.P.3
  • 21
    • 14844300868 scopus 로고    scopus 로고
    • A pilot dose-escalation safety study of tenecteplase in acute ischemic stroke
    • DOI 10.1161/01.STR.0000154872.73240.e9
    • Haley, E. C., Lyden, P. D., Johnston, K. C., & Hemmen, T. M. (2005). A pilot dose-escalation safety study of tenecteplase in acute ischemic stroke. Stroke, 36(3), 607-612. (Pubitemid 40344164)
    • (2005) Stroke , vol.36 , Issue.3 , pp. 607-612
    • Haley Jr., E.C.1    Lyden, P.D.2    Johnston, K.C.3    Hemmen, T.M.4
  • 22
    • 77950251479 scopus 로고    scopus 로고
    • Phase IIB/III trial of tenecteplase in acute ischemic stroke: Results of a prematurely terminated randomized clinical trial
    • Haley, E. C., Jr., Thompson, J. L., Grotta, J. C., Lyden, P. D., Hemmen, T. G., Brown, D. L., Levin, B. (2010). Phase IIB/III trial of tenecteplase in acute ischemic stroke: Results of a prematurely terminated randomized clinical trial. Stroke, 41(4), 707-711.
    • (2010) Stroke , vol.41 , Issue.4 , pp. 707-711
    • Haley Jr., E.C.1    Thompson, J.L.2    Grotta, J.C.3    Lyden, P.D.4    Hemmen, T.G.5    Brown, D.L.6    Levin, B.7
  • 24
    • 0020472522 scopus 로고
    • Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin
    • Hoylaerts, M., Rijken, D. C., Lijnen, H. R., & Collen, D. (1982). Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin. Journal of Biological Chemistry, 257(6), 2912-2919. (Pubitemid 12118804)
    • (1982) Journal of Biological Chemistry , vol.257 , Issue.6 , pp. 2912-2919
    • Hoylaerts, M.1    Rijken, D.C.2    Lijnen, H.R.3    Collen, D.4
  • 25
    • 78349294866 scopus 로고    scopus 로고
    • Part 11: Adult stroke: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care
    • Jauch, E. C., Cucchiara, B., Adeoye, O., Meurer, W., Brice, J., Chan, Y. Y., Hazinski, M. F. (2010). Part 11: Adult stroke: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation, 122(18, Suppl. 3), S818-S828.
    • (2010) Circulation , vol.122 , Issue.18 SUPPL. 3
    • Jauch, E.C.1    Cucchiara, B.2    Adeoye, O.3    Meurer, W.4    Brice, J.5    Chan, Y.Y.6    Hazinski, M.F.7
  • 26
    • 0345327773 scopus 로고    scopus 로고
    • Blood pressure reduction in ischemic stroke: A two-edged sword?
    • Johnston, K. C., & Mayer, S. A. (2003). Blood pressure reduction in ischemic stroke: A two-edged sword? Neurology, 61(8), 1030-1031. (Pubitemid 37461930)
    • (2003) Neurology , vol.61 , Issue.8 , pp. 1030-1031
    • Johnston, K.C.1    Mayer, S.A.2
  • 27
    • 0037338484 scopus 로고    scopus 로고
    • Quality improvement and tissue-type plasminogen activator for acute ischemic stroke a cleveland update
    • DOI 10.1161/01.STR.0000056944.42686.1E
    • Katzan, I. L., Hammer, M. D., Furlan, A. J., Hixson, E. D., & Nadzam, D. M. (2003). Quality improvement and tissue-type plasminogen activator for acute ischemic stroke: A Cleveland update. Stroke, 34(3), 799-800. (Pubitemid 36307415)
    • (2003) Stroke , vol.34 , Issue.3 , pp. 799-800
    • Katzan, I.L.1    Hammer, M.D.2    Furlan, A.J.3    Hixson, E.D.4    Nadzam, D.M.5
  • 28
    • 41249090658 scopus 로고    scopus 로고
    • National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate
    • DOI 10.1161/STROKEAHA.107.490375
    • Kleindorfer, D., Lindsell, C. J., Brass, L., Koroshetz, W., & Broderick, J. P. (2008). National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate. Stroke, 39(3), 924-928. (Pubitemid 351619542)
    • (2008) Stroke , vol.39 , Issue.3 , pp. 924-928
    • Kleindorfer, D.1    Lindsell, C.J.2    Brass, L.3    Koroshetz, W.4    Broderick, J.P.5
  • 29
    • 0036093482 scopus 로고    scopus 로고
    • Blood pressure and clinical outcomes in the International Stroke Trial
    • DOI 10.1161/01.STR.0000014509.11540.66
    • Leonardi-Bee, J., Bath, P. M., Phillips, S. J., & Sandercock, P. A. (2002). Blood pressure and clinical outcomes in the International Stroke Trial. Stroke, 33(5), 1315-1320. (Pubitemid 34517053)
    • (2002) Stroke , vol.33 , Issue.5 , pp. 1315-1320
    • Leonardi-Bee, J.1    Bath, P.M.W.2    Phillips, S.J.3    Sandercock, P.A.G.4
  • 30
    • 0842289216 scopus 로고    scopus 로고
    • Hyperglycemia in acute stroke
    • DOI 10.1161/01.STR.0000115297.92132.84
    • Lindsberg, P. J., & Roine, R. O. (2004). Hyperglycemia in acute stroke. Stroke, 35(2), 363-364. (Pubitemid 38174407)
    • (2004) Stroke , vol.35 , Issue.2 , pp. 363-364
    • Lindsberg, P.J.1    Roine, R.O.2
  • 31
    • 84984763363 scopus 로고    scopus 로고
    • Mechanisms, challenges and opportunities in stroke
    • DOI 10.1038/nrn1106
    • Lo, E. H., Dalkara, T., & Moskowitz, M. A. (2003). Mechanisms, challenges and opportunities in stroke. Nature Reviews of Neuroscience, 4(5), 399-415. (Pubitemid 37280178)
    • (2003) Nature Reviews Neuroscience , vol.4 , Issue.5 , pp. 399-415
    • Lo, E.H.1    Dalkara, T.2    Moskowitz, M.A.3
  • 32
    • 0036284568 scopus 로고    scopus 로고
    • Thrombolysis-related hemorrhagic infarction: A marker of early reperfusion, reduced infarct size, and improved outcome in patients with proximal middle cerebral artery occlusion
    • DOI 10.1161/01.STR.0000016323.13456.E5
    • Molina, C. A., Alvarez-Sabin, J., Montaner, J., Abilleira, S., Arenillas, J. F., Coscojuela, P., Codina, A. (2002). Thrombolysis-related hemorrhagic infarction: A marker of early reperfusion, reduced infarct size, and improved outcome in patients with proximal middle cerebral artery occlusion. Stroke, 33(6), 1551-1556. (Pubitemid 34619956)
    • (2002) Stroke , vol.33 , Issue.6 , pp. 1551-1556
    • Molina, C.A.1    Alvarez-Sabin, J.2    Montaner, J.3    Abilleira, S.4    Arenillas, J.F.5    Coscojuela, P.6    Romero, F.7    Codina, A.8
  • 33
    • 0028783948 scopus 로고
    • Tissue plasminogen activator for acute ischemic stroke
    • National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group
    • National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. (1995). Tissue plasminogen activator for acute ischemic stroke. The New England Journal of Medicine, 333(24), 1581-1587.
    • (1995) The New England Journal of Medicine , vol.333 , Issue.24 , pp. 1581-1587
  • 34
    • 0343990052 scopus 로고    scopus 로고
    • Generalized efficacy of t-PA for acute stroke: Subgroup analysis of the NINDS t-PA Stroke Trial
    • National Institute of Neurological Disorders and Stroke t-PA Stroke Study Group
    • National Institute of Neurological Disorders and Stroke t-PA Stroke Study Group. (1997). Generalized efficacy of t-PA for acute stroke: Subgroup analysis of the NINDS t-PA Stroke Trial. Stroke, 28(11), 2119-2125.
    • (1997) Stroke , vol.28 , Issue.11 , pp. 2119-2125
  • 36
    • 0036288571 scopus 로고    scopus 로고
    • Acute hyperglycemia adversely affects stroke outcome: A magnetic resonance imaging and spectroscopy study
    • DOI 10.1002/ana.10241
    • Parsons, M. W., Barber, P. A., Desmond, P. M., Baird, T. A., Darby, D. G., & Byrne S., Davis, S. M. (2002). Acute hyperglycemia adversely affects stroke outcome: A magnetic resonance imaging and spectroscopy study. Annals of Neurology, 52(1), 20-28. (Pubitemid 34693739)
    • (2002) Annals of Neurology , vol.52 , Issue.1 , pp. 20-28
    • Parsons, M.W.1    Barber, P.A.2    Desmond, P.M.3    Baird, T.A.4    Darby, D.G.5    Byrnes, G.6    Tress, B.M.7    Davis, S.M.8
  • 37
    • 0027972533 scopus 로고
    • Pathophysiology and management of hypertension in acute ischemic stroke
    • Phillips, S. J. (1994). Pathophysiology and management of hypertension in acute ischemic stroke. Hypertension, 23(1), 131-136. (Pubitemid 24022054)
    • (1994) Hypertension , vol.23 , Issue.1 , pp. 131-136
    • Phillips, S.J.1
  • 38
    • 0030039285 scopus 로고    scopus 로고
    • Body temperature in acute stroke: Relation to stroke severity, infarct size, mortality, and outcome
    • DOI 10.1016/S0140-6736(96)90008-2
    • Reith, J., Jorgensen, H. S., Pedersen, P. M., Nakayama, H., Raaschou, H. O., Jeppesen, L. L., Olsen, T. S. (1996). Body temperature in acute stroke: Relation to stroke severity, infarct size, mortality, and outcome. The Lancet, 347(8999), 422-425. (Pubitemid 26054066)
    • (1996) Lancet , vol.347 , Issue.8999 , pp. 422-425
    • Reith, J.1    Jorgensen, H.S.2    Pedersen, P.M.3    Nakayama, H.4    Raaschou, H.O.5    Jeppesen, L.L.6    Olsen, T.S.7
  • 41
    • 0033765853 scopus 로고    scopus 로고
    • Determinants of use of emergency medical services in a population with stroke symptoms: The Second Delay in Accessing Stroke Healthcare (DASH II) Study
    • Schroeder, E. B., Rosamond, W. D., Morris, D. L., Evenson, K. R., & Hinn, A. R. (2000). Determinants of use of emergency medical services in a population with stroke symptoms: The Second Delay in Accessing Stroke Healthcare (DASH II) Study. Stroke, 31(11), 2591-2596.
    • (2000) Stroke , vol.31 , Issue.11 , pp. 2591-2596
    • Schroeder, E.B.1    Rosamond, W.D.2    Morris, D.L.3    Evenson, K.R.4    Hinn, A.R.5
  • 42
    • 0033616490 scopus 로고    scopus 로고
    • Prevalence of admission hyperglycaemia across clinical subtypes of acute stroke
    • DOI 10.1016/S0140-6736(05)74948-5
    • Scott, J. F., Robinson, G. M., French, J. M., O'Connell, J. E., Alberti, K. G., & Gray, C. S. (1999). Prevalence of admission hyperglycaemia across clinical subtypes of acute stroke. The Lancet, 353(9150), 376-377. (Pubitemid 29088169)
    • (1999) Lancet , vol.353 , Issue.9150 , pp. 376-377
    • Scott, J.F.1    Robinson, G.M.2    French, J.M.3    O'Connell, J.E.4    Alberti, K.G.M.M.5    Gray, C.S.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.